New drug combo tested in fight against tough pancreatic cancer
Disease control
Recruiting now
This early-stage trial is testing the safety and best dose of a new drug called ProAgio when given alongside standard chemotherapy for advanced pancreatic cancer. It will enroll about 46 adults who have not yet received treatment for their metastatic disease. The main goal is to …
Phase: PHASE1 • Sponsor: ProDa BioTech, LLC • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC